🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 74168J101
- Market Cap
- Large Cap
- IPO
- 10/20/2022 · $17.00/share
Business: Prime Medicine, Inc. is a biotechnology company committed to delivering a new class of differentiated, one-time, curative genetic therapies to address the widest spectrum of diseases. The company is deploying Prime Editing technology, a versatile, precise, efficient and broad gene editing technology, which is designed to make only the right edit at the right position within a gene.
Company Contact
- CEO
- Allan Reine
- CFO
- Allan Reine
- Headquarters
- 21 Erie Street, Cambridge, MA 02139
- Phone
- 617-564-0013
- Investor Relations
- Gregory Dearborn · 857-209-0696 · gdearborn@primemedicine.com